Vitamin C deficiency and risk of myocardial infarction: Prospective population study of men from eastern Finland

British Medical Journal

Volumn 314, Issue 7081, 1997, Pages 634-638

  Nyyssönen, Kristiina ^a   Parviainen, Markku T ^b   Salonen, Riitta ^c   Tuomilehto, Jaakko ^b   Salonen, Jukka T ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CAROTENE; SATURATED FATTY ACID;

ACUTE HEART INFARCTION; ADULT; ARTICLE; ASCORBIC ACID DEFICIENCY; DIETARY FIBER; DIETARY INTAKE; DISEASE ASSOCIATION; FAT INTAKE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SEASONAL VARIATION; TEA; VITAMIN BLOOD LEVEL;

EID: 0031046270     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.314.7081.634     Document Type: Article

References (49)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. A'£;(gf/MM 1989;320;915-24.
2. Halliwell B. Free radicals, anüoxidants, and human disease: curiosity, cause, or consequence? Lancet 199144:721-4.
3. Salonen JT. Epidemiological studies on LDL oxidation, pro- and aniioxidants and atherosclerosis. In: Bellomo G, Finardi G, Maggi E, Rice-Evans C, eels. Free radicals, lipoprotein oxidation and atherosclerosis. London: Richelieu Press, 1995.
4. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that aniioxidanis in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks slowing the progression of atherosclerosis in die WHHL rabbit Pnx Xatl Acad Sci USA 1987;84:7725-9.
5. Björkhem I, Henriksson-Freyschuss A, Breuer O, Diczafalusy U, Berglund L, Henriksson P. Tlie antioxidant butylated hydrox)toluene protects against atherosclerosis. Arterioscler Thromb 1991;11:15-22,
6. Freyschuss A, Stiko-Ralim A, Swedenborg J, Henriksson P, Björkhem I, Berglund L, et al. Antioxidant treatment inhibits die development of intimal. thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J Clin Invest 1993;91:1282-8.
7. Williams RJ, Motteram JM, Sharp CU, Gallagher PJ. Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis 1992;91:153-60.
8. Stampfer MJ, I lennekens CH, Manson JE, Coditz GA, Rosner B, Wülett WC. Vitamin E consumption and risk of coronary disease in women. A' Eng J Med 1993:328:1444-9.
9. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willet WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-6.
10. Salonen JT, Nyyssönen K, Korpela 11, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-11.
11. Salonen JT, Nyyssöncn K, Salonen R. Body iron stores and the risk of coronary heart disease. New Eng J Med 1994;331:1159.
12. Salonen JT, Seppanen K, Nyyssönen K, Korpela H, Kauhanen J, Kantola M, et al. Intake of mercury from fish, lipid peroxidation and the risk of myocardial infarction and coronary, cardiovascular and any death in Eastern Finnish men. Circulation 1995;91:645-55.
13. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992;339:883-7.
14. Maggi E, Finardi G, Poli M, Bollati P, FÜipponi M, Stefano PL, et al. Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk. Coron Artery Dis 1993;4:1119-22.
15. Regnström J, NUsson J, Tornvall P, Landou C, Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992339:1183-6.
16. Salonen JT, Salonen R, Seppanen K, Kantola M, Suntioinen S, Korpela 11. Interactions of serum copper, selenium, and low density lipoprotein cholesterol in aihcrogenesis. BMJ 1991;302:756-60.
17. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 1989;86:6377-81.
18. Salonen JF. Is there a continuing need for longitudinal epidemiologic research- the Kuopio ischaemic heart disease risk factor study. Ann Clin Res 1988;20:46-50.
19. Lakka TA, Venalainen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction in men. N Engl Med 1991:330:1549-54.
20. Parviainen MT, N'yyssönen K, Pentüli IM, Seppanen K, Rauramaa R, Salonen JT, et al. A method for routine assay of plasma ascoibic acid using high-performance liquid chromatography. y Liq Chwmalogr 1986;9:2185-97.
21. Carry PJ, Goodwin JS, Hunt WC, Gilbert BA. Nutritional status in a healthy population: vitamin C. Am] Clin Nutr 1982;36:332-9.
22. Parviainen MT, Salonen JT. Vitamin C status of 54-year old Eastern Finnish men throughout the year. Int J Nutr Res 1990;60:47-51.
23. Salonen JT, Salonen R, Seppanen K, Rauramaa R, Tuomilehto J. HDL, HDIx, and HDL, subfractions, and die risk of acute myocardial infarction. A prospective population study in eastern Finnish men. Circulation 1991;84:129-39.
24. Salonen JT, Salonen R, Korpela H, Tuomilehto J. Serum copper and the risk of acute myocardial infarction: a prospective population study in men in Eastern Finland. Am J Epidemiol I991;134:2G8-76.
25. Ihanainen M, Salonen R, Seppanen K, Salonen JT Nutrition data collection in the Kuopio ischaemic heart disease risk factor study: nutrient intake of middle-aged Eastern Finnish men. Nutr Res 1989:9:597-604.
26. Kauhanen J, Julkunen J, Salonen JT. Coping with inner feelings and stress: heavy alcohol use in the context of alcxithyiiiia. Belunj Med 1992;18:121-G.
27. Kaplan GA, Salonen JT. Socioeconomic conditions in childhood and ischaemic heart disease during middle age. B. MJ 1990;301:1121-3.
28. Lakka T, Salonen JT. Physical activity and scrum lipids: a cross-sectional population study in Eastern Finnish men. Am J Epidemiol 1992:136:80618.
29. WHO Monica Project. WHO Monica Project: assessing coronary heart disease mortality and moibidity. Int J Epidemiol 1989;18:S38-45.
30. Tuomilehto J, Arstila M, Kaarsalo E, Kankaanpaa J, Ketonen M, Kuulasmaa K, et al. Acute myocardial infarction (AMI) in Finlandbaseline data from the FIXMONICA AMI register in 1983-1985. Eur Heart J 1992;13:577-87.
31. Cox DR. Regression models and life-tables. J R Stat Soc 197234:187-201.
32. SPSS. SPSS for UNIX. Cliicago: SPSS, 1993.
33. Frei B, Stocker R, England L, Ames BN. Ascorbate: the most effective anüoxidant in human blood plasma. Ada Exp Med Biol 1990;264:155-63.
34. Jialal I, Grundy SM. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. J Clin Invest 1991;87:597-601.
35. Harats D, Ben-Nairn M, Dabach Y, Hollander G, Havivi E, Stein Y. Effect of vitamin C and E susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis 1990;85:47-54.
36. Frei B. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage, Amy Clin A'ufr 1991;54:1113-88.
37. Packer JE, Slater TF, Willson RL. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979;278:737-8.
38. Kagan VE, Serbinova EA, Forte T, Scita G, Packer L. Recycling of vitamin E in human low density lipoproteins. /Lipid Res I992;33;385-97.
39. Retsky KL, Frei B. Vitamin C prevents metal ion-dependent initiation and propagation of lipid peroxidation in human low-density lipoprotein. Biochim Biophys Acta 1995;1257:279-87.
40. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. Does Superoxide underlie the pathogenesis of hypertension? froc Nail Aead Sci USA 1991;88:10045-8.
41. Salonen JT, Salonen R, Ihanainen M, Parviainen M, Seppanen R, Kantola M, Seppanen K, et al. Blood pressure, dietary fats and antioxidants. Am J Clin Kutr 1988;48:1226-32.
42. Salonen R, Korpela H, Nyyssönen K, Porkkala E, Salonen JT Reduction of blood pressure by antioxidant supplementation: a randomised double-blind clinical trial. Life Chemistry Reports 1991;12:65-8.
43. Salonen JT. Dietary fats, antioxidants and blood pressure. Ann Med 1991;23:295-8.
44. Enstrom JE, Kanim LE, Lein MA. Vitamin C intake and mortality among sample of the United States population. Epidemiology 1992:3:191-202.
45. Eiclmolzer M, Stahelin HB, Gey KF. Inverse correlation between essential antioxidants in plasma and subsequent risk to develop cancer, ischémie heart disease and stroke respectively: 12-year follow-up of die Basel study. EXS 1992;62:393-410.
46. Gey KF, Stahclin HB, Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischémie heart disease and stroke: Basel prospective study. Clin Invest 1993;71:3-6.
47. Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliövaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am JEpidemiol 1991;139:1180-9.
48. Gale CR, Martyn CN, Winter I'D, Cooper C. Vitamin C and risk of deatli from stroke and coronary heart disease in cohort of elderly people. BMJ 1995:310:1563-6.
49. Riemersma RA, Wood DA, Madntyre CCA, Elton RA, Gey KF, Oliver MF. Risk of angina pcctoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991:337:1-5.